Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Remote ischemic conditioning wikipedia , lookup
Aortic stenosis wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Drug-eluting stent wikipedia , lookup
Cardiac surgery wikipedia , lookup
History of invasive and interventional cardiology wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Coronary artery disease wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
MYOCARDIAL PROTECTION DEFINITION: It is defined as specific intra op technique designed to protect heart from ischemic state associated with extra corporeal circulation. TECHNIQUE: Most cardiac operations are performed with cardioplegia and a period of ACC. This technique provides the surgeon still and bloodless field. Application of ACC isolates coronary circulation from blood volume circulating through CPB but not all the blood flow to myocardium is eliminated Non coronary collaterals in pericardial attachments and pulmonary vein walls continue to provide some blood flow during period of ACC. HYPOTHERMIA: A combination of 3 techniques to achieve to moderate systemic and profound myocardial hypothermia Systemic cooling of blood as it passes through CPB Topical cooling of heart with cold solution Infusion of coronary artery with chilled CP SYSTEMIC HYPOTHERMIA / CORE COOLING: Cooling to 28*c to 32*c is induced at onset of CPB to reduce cellular metabolic demands of myocardium. When systemic hypothermia has been achieved, the ventricle fibrillates. At this point, occlusive clamp is applied to aorta , proximal to aortic cannula used for arterial return from CPB circuit. TOPICAL / SURFACE COOLING: Reduce rewarming between the doses of CP , performed by bathing the heart continuously or intermittently with ice cold saline / RL . Care is taken to avoid exposing left side of pericardium containing phrenic nerve to iced solution to avoid nerve injury. An isolating pad may also be placed between and the left side of pericardium for this purpose. As an alternative to bathing, a cooling pad or jacket may be wrapped around the heart .Ventricular temperature is measured by thermistor probe placed on LV myocardium. With these measures myocardium temperature to 10*c. CARDIOPLEGIA: Induction and maintenance of the heart in an arrested state using a solution infused into coronary artery circulation.To protect against ischemic injury during ACC when normal antegrade coronary artery blood flow is absent. Categories: Autologous blood Crystalloids Oxygenated crystalloids Autologous blood cardioplegia has been preferred type in 72% of cardiac operations , crystalloid CP in 22% , oxygenated crystalloid CP in 6%. Advantages of blood CP: Less systemic hemodilution Delivery of oxygen and provision of exogenous buffer Free radical scavengers Proteins to control oncotic pressure ADMINISTRATION OF CP Antegrade: Infusing through catheter placed proximal to ACC in aortic root. With a competent AV and aorta clamped distal to catheter , CP solution passes directly into coronary artery . Aortic root pressure is measured simultaneously through a separate catheter during infusion of CP. Cold CP: Most often,cardiac arrest is induced and maintained with cold CP.Used when a fast decrease in energy metabolism is preferable. Warm CP: CP delivered at normothermic temperature , for patients with acute ischemia. An oxygenated CP solution at normothermia as initial dose to induce cardiac arrest increase myocardial oxygen uptake is thought to provide additional benefit in patients with acute ischemia. Warm CP induction usually is followed by intermittent doses of cold CP to prevent myocardial ischemia during ACC. Intial doses of 1-1.5lt cold CP – antegrade technique , rate of administration is adjusted to maintain aortic root pressure between 80-100mmhg to ensure effective delivery of solution and achieve rapid diastolic arrest. Global cardiac arrest occurs in 30 sec of CP infusion but may take 1-2min in presence of stenotic / occlude coronaries.because the blood flow from non coronary collateral arteries washes away infused CP solution and gradually rewarms heart Intermittent infusion of 500 – 750ml of CP administration every 20mn during period of ACC. Retrograde CP: Catheter is introduced through the right atrial wall and guided by digital manipulation into coronary sinus , then coronary veins and perfuse myocardium. Many use a combination of antegrade and retrograde CP.Usually initial dose is given using an antegrade route with subsequent doses in retrograde infusion for better myocardial cooling distal to disease arteries. Retrograde CP is used in AVR with AR.as an alternative CP infused through small individual catheter / cannulae directly placed into ostio of coronary artery. Antegrade CP delivery during bypass grafting is limited due to; Jeoparadised myocardium does not receive CP untill distal anastomosis to supplying artery is constructed. Muscle supplied by an artery receiving IMA pedicle graft is not revascularised until end of ACC period. CP solution can be injected directly into proximal end of vein graft after completion of distal anastomosis / infused in retrograde fashion while proximal anastomosis is being constructed. If the proximal anastomosis are done first , CP delivered into aortic root after ACC will flow through graft to myocardium it supplies as soon as distal anastomosis is constructed. Administration of CP through graft is not possible when IMA is used as it proximal attachement to subclavian artery is left intact. Blood product Coagulation factor fibrinogen FFP 1u/ml 2-4mg/ml Platelet 2u/ml except factor V,VIII 4-8mg/ml Cryo 5u/ml 10mg/ml